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Abstract This study aims to evaluate and verify the
relationship between the immunoexpression of hMSH2,
p53 and p21 in actinic cheilitis (AC) and lower lip squa-
mous cell carcinoma (SCC) cases. Forty AC and 40 SCC
cases were submitted to immunoperoxidase method and
quantitatively analyzed. Expression was compared by
Mann–Whitney test, Student t test or one-way ANOVA. To
correlate the variables, Pearson’s correlation coefficient
was calculated. The expression of p53 and p21 showed no
significant differences between histopathological grades of
AC or lower lip SCC (p[ 0.05). Immunoexpression of p53
was higher in SCC than in AC (p\ 0.001), while p21
expression was more observed in AC when compared to
SCC group (p = 0.006). The AC group revealed an inverse
correlation between p53 and hMSH2 expression
(r = -0.30, p = 0.006). Alterations in p53 and p21
expression suggest that these proteins are involved in lower
lip carcinogenesis. Moreover, p53 and hMSH2 seem to be
interrelated in early events of this process.
Keywords Actinic cheilitis  Squamous cell carcinoma 
Lip carcinogenesis  Oral cancer
Introduction
Actinic cheilitis (AC) is a potentially malignant disease
that can display varied degrees of epithelial dysplasia and
may progress to squamous cell carcinoma (SCC) of the
lower lip [39, 42]. Both lesions have similar characteristics
with skin lesions and also share the same main etiological
agent, ultraviolet (UV) radiation, particularly the UVB
[33]. The carcinogenesis process induced by UV, is still not
fully elucidated, but it is known that exposure to endoge-
nous and exogenous genotoxic agents, such as UV, can
lead to oncogenic mutations resulting from perturbation of
the cell cycle and damage to DNA repair systems [15, 30,
31].
Loss of genomic stability is orchestrated by an interac-
tion between the repair system of badly paired bases genes
(MMR—mismatch repair), tumor suppressor genes and
oncogenes [14, 36]. The hMSH2 gene, the main component
of the MMR repair system, has been extensively studied
[12]. Inactivation of hMSH2 induces a decrease in the
function of the mismatch repair and, therefore, leads to
microsatellite instability (MSI). MSI induces the activation
of oncogenes or inactivation of tumor suppressor genes,
which can initiate cellular carcinogenesis [12, 26, 32]. Our
group have described that low immunoexpression of
hMSH2 is an early event in the carcinogenesis of lower lip
cancer in a previous study [33]. We found a significantly
higher expression of hMSH2 in ACs with absent/mild
dysplasia than in the group with moderate or severe dys-
plasia. In the lower lip SCC cases, the comparison of
positive-hMSH2 cells showed a slightly higher expression
in low grade of malignancy than in the high-grade ones, but
this result was not statistically significant. The comparison
of hMSH2 immunoreactivity among different lesions
revealed that the mean positive epithelial cells significantly
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decreased, as the lesion was morphologically more
aggressive. Therefore, the ACs classified as absent/mild
dysplasia showed the highest mean of positive cells, the
moderate/severe dysplasia group showed intermediate
values and the SCCs exhibited the lowest means.
The relationship between MMR genes and function of the
p53 tumor suppressor gene has been of interest since that
p53 is essential in the protection of cell DNA damage
induced by UVB radiation, by promoting cell cycle arrest or
apoptosis of damaged cells [1, 12, 31, 37]. Activation of p53
induces the expression of several genes, including cyclin-
dependent kinase inhibitor p21WAF1/CIP1 gene (p21) [18, 19].
The DNA alkylating agents induce the phosphorylation and
activation of p53, leading to an increase in p21 expression
[6]. Thus, p21 may suppress tumors by its function in
mediated p53-dependent G1 growth arrest [20]. Despite this,
paradoxical oncogenic effects have been linked to p21,
especially by its anti-apoptotic activity [27, 41].
The aim of the present study was to evaluate the
epithelial immunoexpression of p53 and p21 proteins in
AC and SCC of the lower lip and then analyze the rela-
tionships between these proteins and the previously
reported hMSH2 expression in the same sample [33], to
determine the participation of these proteins in different
morphological stages of carcinogenesis lip.
Materials and methods
Tissue specimens
The study was approved by the Research Ethics Committee
of UFRN (CEP/UFRN-028/2010). This retrospective study
analyzed 40 cases of AC (male-to-female ratio = 3:1;
mean age = 53.5 ± 17.04 years) and 40 cases of lower lip
SCC (male-to-female ratio = 3:1; mean age = 61.28 ±
20.18 years), obtained from stored tissue blocks of the
Laboratory of Oral Pathology, Department of Dentistry,
Federal University of Rio Grande do Norte (UFRN), Natal,
Rio Grande do Norte, and from the Scientific Diagnostic
Center (SDC), Campina Grande, Paraı´ba, Brazil. The cases
were intentionally selected on basis of the histopathologi-
cal diagnosis. The diagnosis of AC or SCC of the lower lip
was confirmed by reviewing the clinical and histopatho-
logical data in the patient records, as performed by Sar-
mento et al. [33].
Morphological study
For morphological analysis, 5-lm-thick sections were
embedded in paraffin blocks, stained with hematoxylin/
eosin, and examined by light microscopy. The cases of
lower lip SCCs were classified as high and low grade of
malignancy according to the histological grading system
proposed by Bryne [4]. The 2005 morphological criteria of
the World Health Organization (WHO) [3] were used to
determine the degree of epithelial dysplasia in cases of AC.
Twenty-two (55.0 %) of the 40 cases of lower lip SCC
were classified as low grade of malignancy and 18
(45.0 %) as high grade. With respect to the degree of
epithelial dysplasia in the 40 cases of AC, no dysplasia was
observed in 16 (40.0 %), mild dysplasia in 10 (25.0 %),
moderate dysplasia in 11 (27.5 %), and severe dysplasia in
3 (7.5 %).
Immunohistochemistry
Primary mouse monoclonal antibodies against p53 and p21
were used. For our previous study [33], the specimens of
this sample were stained with monoclonal antibody against
hMSH2. The specifications of the primary antibodies
(clone, manufacturer, dilution, antigen retrieval and incu-
bation) are shown in Table 1. After antigen retrieval,
endogenous peroxidase was blocked with a 1:1 solution of
methanol and 3 % hydrogen peroxide. Antibodies were
detected by immunoperoxidase staining using a dextran
polymer-based signal enhancement technique (ADVAN-
CETM, Dako, Carpinteria, CA, USA). The reaction was
developed with diaminobenzidine as chromogen. The
sections were counterstained with Mayer’s hematoxylin
and mounted in Permount (Fisher Scientific, Fair Lawn,
NJ, USA). Negative controls consisted of the replacement
of the primary antibodies with bovine serum albumin; and
samples of normal oral mucosa and colon carcinoma with
known positive reactivity were included as positive con-
trols. A colon carcinoma specimen previously shown to be
strongly positive for the antibodies analyzed was used as
positive control. Only epithelial cells that exhibited brown
nuclear immunoreactivity were considered to be positive,
irrespective of the intensity of staining.
Quantification of immunostained cells
For the quantification of immunostained cells in AC, no
distinction between the basal and suprabasal layers was
made. According to Caldeira et al. [5], it is more relevant to
consider the epithelium as a whole than to evaluate
epithelial layers separately. In the cases of lower lip SCC,
immunostaining was evaluated at the invasion front. Areas
showing the highest immunostaining were analyzed in the
two groups.
All specimens were examined under a light microscope
(Olympus CH30, Olympus Co., Tokyo, Japan). First, the
area with the largest number of immunostained cells was
identified in the slide at 2009 magnification. Next, an
Infinity 1-3C camera (Lumenera Co., Ottawa, Canada)
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coupled to a light microscope (Nikon Eclipse E200MV,
Nikon, Tokyo, Japan) was used to photograph 10 consec-
utive fields of each specimen at 4009 magnification. The
captured images were processed using the Lumenera
Infinity Analyze software, version 5.0.3. Epithelial cells
exhibiting brown nuclear staining were considered to be
positive. Positive and negative cells were counted in each
field using the ImageJ program (ImageJ for Mac OS X,
version 1.44, 64 bit Java) until a number of 1000 cells was
reached. This approach permitted a more reliable com-
parison of the data since the number of cells was the same,
irrespective of the lesion analyzed.
Statistical analysis
The data were analyzed using the SPSS 20.0 software
(SPSS, Inc., Chicago, IL, USA) and submitted to specific
tests, adopting a level of significance of 5 %. Since p53
data showed a normal distribution, the Student t test was
used to compare the mean immunoexpression of this pro-
tein. The p21 data showed a nonparametric distribution;
thereby the Mann–Whitney test was used to compare the
immunoexpression of this protein. Correlation between the
levels of hMSH2, p53 and p21 expression was calculated
using Pearson’s and Spearman’s correlation coefficient.
Results
p53 immunohistochemistry
All cases of AC and SCCs of the lower lip revealed posi-
tivity to p53. Comparison of the two types of lesion showed
a significant higher p53 expression in the lower lip SCCs
(561.33 ± 228.70), than in the AC cases
(208.48 ? 147.27) (p\ 0.001; Table 2).
There was no significant difference in p53 expression
between ACs with moderate/severe dysplasia (249.14 ?
146.53) when compared with the absent/mild dysplasia
group (186.58 ? 145.76; Fig. 1a) (p[ 0.05; Table 3). With
respect to lower lip SCCs, no significant difference was
observed between the mean number of p53-positive neo-
plastic epithelial cells between low-grade cases (Fig. 1b)
when compared to high-grade SCCs (p[ 0.05; Table 3).
p21 immunohistochemistry
P21 staining was present in 29 (72.5 %) of the 40 AC
specimens, with a pattern of nuclear expression mainly in
the basal and suprabasal layers. When different lesions
were compared, the AC cases showed a significant higher
median immunoexpression of p21 than lower lip SCCs
(p\ 0.05) (Table 4).
Comparison of p21 expression between AC cases with
different degrees of epithelial dysplasia showed higher
expression of this protein in mild lesions (absent/mild
dysplasia) (Fig. 1c) but this difference was not significant
(p[ 0.05) (Table 5). Analysis of lower lip SCC revealed
24 (60 %) positive cases, showing expression restricted to
the nucleus of neoplastic cells. A larger median number of
p21-positive neoplastic epithelial cells in low-grade cases
(Fig. 1d) was observed when compared to high-grade
SCCs (p[ 0.05) (Table 5).
Correlation between the levels of hMSH2, p53
and p21 expression
Spearman’s correlation coefficient was calculated to assess
the possible correlations between the hMSH2 and p21, and
between p53 and p21 expression. No correlation could be
noted between hMSH2 and p21 (r = 0.273, p = 0.08) or
p53 and p21 (r = 0.015, p = 0.926) in AC cases. In lower
lip SCC, no significant correlation was found between
hMSH2 and p21 (r = -0.105, p = 0.517) or p53 and p21
proteins (r = 0.123, p = 0.450).
Table 1 Primary antibody, clone, manufacturer, dilution, antigen retrieval and incubation
Primary antibody Clone Manufacturer Dilution Antigen retrieval Incubation
Anti-hMSH2 [2] G219-1129 Pharmingen (San Diego, CA, USA) 1:200 No antigen retrieval Overnight (18 h)
Anti-p53 DO-7 Dako (Carpinteria, CA, USA) 1:400 Citrate, pH6.0, Pascal 300
Anti-p21 4D10 Dako (Carpinteria, CA, USA) 1:50 Tris–EDTA, pH9.0, Pascal 600
Natal, RN-2014
Table 2 p53 immunoexpression and comparison between means of
AC and SCC
Lesion p53 immunoexpression
n Mean ± SD pa
AC 40 216.85 ± 143.47 \0.001*
SCC 40 561.33 ± 228.70
Natal, RN-2014
AC actinic cheilitis, SCC squamous cell carcinoma, SD standard
deviation
* Results are statistically significant
a Student t test
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Possible correlations between the expression of hMSH2
and p53 were investigated by the Pearson’s correlation
analysis. In AC cases, the level of hMSH2 expression was
inversely correlated to the expression of p53 protein
(r = -0.30, p = 0.006) (Fig. 2). In lower lip SCCs, p53
and hMSH2 showed no correlation (r = -0.04,
p = 0.777).
Discussion
Among of the disorders that can undergo a process of
malignant transformation there is the AC, which in some
situations can turn into SCC of the lower lip [9, 21]. The
rate for malignant transformation of these lesions ranges
from 10 to 30 % [28] and solar radiation is the main eti-
ological factor in its development and consequent pro-
gression to SCC [9, 28].
Genetic damage caused by ultraviolet radiation is usually
repaired, especially via DNA repair [29]. Defective MMR
Fig. 1 Immunohistochemical expression of p53 and p21 in AC and
SCC of the lower lip. a Immunoexpression of p53 in AC with mild
dysplasia and b in SCC of the lower lip low with grade of
malignancy; c immunoexpression of p21 in AC with mild dysplasia
and d in SCC of the lower lip with low grade of malignancy
(ADVANCE; scale bar 100 lm)
Table 3 p53 immunoexpression in AC and SCC and comparison of
means between groups of each lesion
Lesion Degree p53 immunoexpression pa
n Mean ± SD
AC WD/MD 26 199.12 ± 141.38 0.293
MOD/SED 14 249.79 ± 146.69
SCC Low grade 22 570.45 ± 239.15 0.784
High grade 18 550.17 ± 221.59
Natal, RN-2014
AC actinic cheilitis, SCC squamous cell carcinoma, WD without
dysplasia, MD mild dysplasia, MOD moderate dysplasia, SED severe
dysplasia, SD standard deviation
a Student t test
Table 4 Sample, median, quartiles 25 and 75 of p21 immunoex-
pression between AC and SCC
Lesion n Median Q25–Q75 Mean rank p
a
AC 40 34.5 0–104.75 47.53 0.006*
SCC 40 4 0–26.5 33.48
Natal, RN-2014
AC actinic cheilitis, SCC squamous cell carcinoma
* Results are statistically significant
a Mann–Whitney test
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system is a very frequent genetic alteration in many
malignancies, including squamous cell carcinoma, and
recent studies have demonstrated these alterations in
potentially malignant disorders, such as AC [33, 35]. In
addition, changes in system MMR genes can cause disorders
in cell cycle proteins such as p53 [22]. Based on this, we
performed the immunohistochemical analysis of cell cycle
proteins p53 and p21 in the same sample used in our pre-
vious study [33] to verify if there is any relationship between
the alterations in hMSH2 expression and the aforementioned
cell cycle proteins in different stages of lip carcinogenesis.
The p53 protein is essential in protecting the cells
against DNA damage induced directly and indirectly by
UV radiation [1, 12, 18]. Immunohistochemical expression
of p53 is largely accepted as a marker of malignant
transformation, and its overexpression has been associated
with malignant potential in potentially malignant lesions of
the head and neck [23, 24]. In the current study, p53 was
present in AC, being slightly higher in AC with moder-
ate/severe dysplasia group than in the no/mild dysplasia
one. This finding confirms previous reports that demon-
strated p53 expression in precancerous skin lesions and in
chronically sun-exposed normal skin, suggesting that p53
mutation is an early event in skin carcinogenesis [7, 25,
43]. Therefore, according to Ba¨ckvall et al. [2] and Mercut¸
et al. [23] the expression of p53 oncoprotein in lesions
localized on facial regions that were typically exposed to
sunlight and these epidermal p53 clones seems to develop
in skin areas chronically exposed to sunlight.
In SCC of the lower lip cases, the present results
revealed that p53 expression was significantly higher in
tumors presenting low grade of malignancy than in high-
grade tumors, similar to other studies [12, 39]. Comparing
the two studied lesions, we found a significantly greater
expression of p53 in cases of SCC of the lower lip than in
the AC ones. Therefore, our data showed that immunore-
activity for p53 protein was observed in both premalignant
and malignant lesions of the lower lip. These data along
with previous studies [13, 23] corroborate and emphasize
that the overexpression of p53 protein is mainly present in
the early stages of oral carcinogenesis process.
The p21 expression is induced through both p53-de-
pendent and independent mechanisms [8, 10, 27]. Its
importance in cell cycle arrest by inhibiting cyclin-de-
pendent kinase, in apoptosis process and terminal differ-
entiation of squamous epithelium has been described [12,
41]. Moreover, as one of its major functions, p21 is known
to regulate differentiation in many different cell lineages
[38]. The present results showed a lower immunostaining
for p21 in AC with moderate/severe dysplasia than in the
group with milder dysplasias; and the lower lip SCC group
exhibited less positive cases than the AC group, the
expression being more evident in SCCs low grade of
malignancy.
The controversial prognostic potential of p21 may be
associated with paradoxical functions performed by this
protein. Even though p21 is best known for its cyclin-de-
pendent kinase inhibitory function, this protein also can
inhibit apoptosis, which might account for its oncogenic
activities [20, 41]. Most of the studies suggested that p21 is
present at the nucleus when considered as a tumor sup-
pressor, and at the cytoplasm when considered as an
oncogene [20]. The significant low nuclear expression of
p21 in lip SCC cases when comparing to AC cases
demonstrated here may reflect the tumor suppression effect
of p21 protein. However, according to Tron et al. [38], p21
Fig. 2 Inverse correlation between p53 and hMSH2 expression in
actinic cheilitis. The best linear fit and statistically significant
correlation are identified in the graph
Table 5 Sample, median, quartiles 25 and 75 of p21 immunoex-
pression in AC and SCC and comparison of mean rank between
groups of each lesion
Lesion n Median Q25–Q75 Mean Rank p
a
AC
WD/MD 26 54.0 7–100.25 21.65 0.390
MOD/SED 14 7.0 0–138.25 18.36
SCC
Low grade 22 6.0 0–29.75 22.82 0.152
High grade 18 0 0–17.25 17.67
Natal, RN-2014
WD without dysplasia, MD mild dysplasia, MOD moderate dysplasia,
SED severe dysplasia
a Mann–Whitney test
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overexpression is associated with differentiation in prolif-
erating cutaneous SCC but is not sufficient to suppress
cancer development.
Even though the p21 deficiency reflects p53 wild-type
inactivation, in AC and lower lip SCC studied, no corre-
lation could be detected between p21 and p53 or hMSH2
expression. As p53 is abnormal or nonfunctional in most
cases of cutaneous SCC, we hypothesized that expression
of the downstream effector of p53 would be lost in these
tumors [38]. Martı´nez et al. [21] did not find significant
correlation between p21 and p53 in their AC sample and
suggested that in earlier stages of lip carcinogenesis p53
could be inefficient to transactivate p21 expression.
There seems to be a close interaction between p53 and
hMSH2 in carcinogenesis. Mutation in the hMSH2 gene
reportedly could lead to activation of p53 mutation, without
previous MSI, in sporadic digestive tract tumors [16].
Therefore, the relationship between p53 and hMSH2 has
been investigated in several cancers [11, 12, 14, 17, 32, 36,
37, 40]. Helal et al. [12] found an inverse correlation between
the level of expression of p53 and hMSH2 in oral SCC. Our
data showed no correlation between these proteins in the
lower lip SCC; however, an inverse correlation was observed
in the AC cases. To our knowledge, this is the first report of
such relationship in AC. Staibano et al. [37] emphasized the
importance of this correlation in the UV-related carcino-
genic process, as they found similar results in basal cell
carcinomas. In fact, DNA damage promoted by UV irradi-
ation has been shown to cause p53-dependent activation of
human mismatch repair hMSH2 gene transcription in vitro,
through functional interaction with c-Jun [34].
In summary, the present study supports the hypothesis
that alterations in the immunoexpression of cell cycle
proteins p53 and p21 are related to lip carcinogenesis.
Additionally, hMSH2 and p53 proteins seem to be inter-
related in early events of this process, but changes in p21
expression seem to be an independent event.
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